Thyroid gland metastasis arising from breast cancer: A case report
- Authors:
- Mei Yang
- Wei Wang
- Chenfang Zhang
View Affiliations
Affiliations: Department of General Surgery, General Hospital of Guangzhou Military Command of PLA, Guangzhou 510010, P.R. China, Department of Pathology, General Hospital of Guangzhou Military Command of PLA, Guangzhou 510010, P.R. China
- Published online on: April 3, 2013 https://doi.org/10.3892/ol.2013.1287
-
Pages:
1836-1838
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Abstract
The thyroid gland is an uncommon site for metastasis to develop and thus metastases arising from breast cancer are rarely observed. In the present study, we describe a case of a 45‑year‑old female with a three-year history of breast cancer who presented with a thyroid mass that was diagnosed as metastatic breast carcinoma by histopathological analysis of the subtotal thyroidectomy specimen. To ascertain the diagnosis of metastatic breast cancer, we evaluated two types of markers; those that possessed a similar expression status in the original and metastatic lesions [ER, PR and CerbB-2 (HER2/neu)], and those that are capable of differentiating between metastatic lesions and the surrounding thyroid components (TG and TTF-1). The results showed that ER, PR and CerbB-2 demonstrated a similar expression pattern in primary breast carcinoma and thyroid lesions. Meanwhile, in the thyroid lesions, the malignant cells showed negative staining for TG and TTF-1, which confirmed that lesions were not thyroid in origin. This case may prompt clinicians that although thyroid gland are uncommon metastatic site, a diagnosis of metastatic disease should be considered when new aggregates are identified in the thyroid glands and histopathological analysis may aid the diagnosis.
View References
1
|
Irvin W Jr, Muss HB and Mayer DK: Symptom
management in metastatic breast cancer. Oncologist. 16:1203–1214.
2011. View Article : Google Scholar : PubMed/NCBI
|
2
|
Lam KY and Lo CY: Metastatic tumors of the
thyroid gland: a study of 79 cases in Chinese patients. Arch Pathol
Lab Med. 122:37–41. 1998.PubMed/NCBI
|
3
|
Gerges AS, Shehata SR and Gouda IA:
Metastasis to the thyroid gland; unusual site of metastasis. J
Egypt Natl Canc Inst. 18:67–72. 2006.PubMed/NCBI
|
4
|
Chen H, Nicol TL and Udelsman R:
Clinically significant, isolated metastatic disease to the thyroid
gland. World J Surg. 23:177–180. 1999. View Article : Google Scholar : PubMed/NCBI
|
5
|
Willis RA: Metastatic Tumours in the
Thyreoid Gland. Am J Pathol. 7:187–208. 1931.PubMed/NCBI
|
6
|
Idirisinghe PK, Thike AA, Cheok PY, et al:
Hormone receptor and c-ERBB2 status in distant metastatic and
locally recurrent breast cancer. Pathologic correlations and
clinical significance. Am J Clin Pathol. 133:416–429. 2010.
View Article : Google Scholar
|
7
|
Wagner K, Arciaga R, Siperstein A, et al:
Thyrotropin receptor/thyroglobulin messenger ribonucleic acid in
peripheral blood and fine-needle aspiration cytology: diagnostic
synergy for detecting thyroid cancer. J Clin Endocrinol Metab.
90:1921–1924. 2005. View Article : Google Scholar
|
8
|
Katoh R, Miyagi E, Nakamura N, et al:
Expression of thyroid transcription factor-1 (TTF-1) in human C
cells and medullary thyroid carcinomas. Hum Pathol. 31:386–393.
2000. View Article : Google Scholar
|